Searched for
ASTRAZENCA
Breakout Stocks: What should traders do with Jindal Saw, KPIT Technologies, and AstraZeneca Pharma on ThursdaySectorally, buying was seen in telecom, consumer durables, realty, and healthcare stocks, while some selling was seen in energy, metal, oil...- Will Biocon's foray into biosimilar boost its bottomline?Biological drugs are harvested from living organisms or certain components of living organisms. These drugs are very specific and highly ef...
- FTSE 100 slips as stronger pound, energy stocks weighThe blue-chip index fell 0.2%, with oil majors BP and Shell down 0.3% each on weaker crude prices.
- Qantas Airways expects to start international flights in OctoberThe Sydney-based airline had been selling seats on international flights from July 1.
- Covid-19 vaccine programme: Adverse events data show jabs safe for useThis data comes as states have reported hesitancy during the immunisation drive, especially among those being injected with Covaxin as it r...
- Govt panel recommends marketing authorisation to Serum Institute’s Covishield vaccine"The Subject Expert Committee has recommended in favour of marketing authoritsation to SII’s vaccine but with certain conditions, a person ...
- Serum's chances for Covishield nod rise after UK regulator approves Oxford COVID-19 vaccineThe SEC was called soon after the UK regulator authorised Oxford University/AstraZeneca’s Covid-19 vaccine for use. The approval by UK regu...
- Serum seeks marketing nod for CovishieldThe SII application appears to be lacking the immunogenicity data from the phase-3 trials which experts say as per timelines would not have...
- Covid-19 vaccine deliveries on ice as AstraZeneca awaits trial dataAstraZeneca said on Thursday it was holding back deliveries while it awaits the data from late-stage clinical trials in order to maximise t...
- Serum Institute of India to also halt trial of the Oxford-AstraZeneca vaccine candidateAZ on Wednesday morning said that it was temporarily halting the trial of the vaccine candidate after one of the participants developed "un...
- AstraZeneca & Serum Institute of India sign licensing deal for 1 billion doses of Oxford vaccineThe British drug maker also reached a $750m agreement with Coalition for Epidemic Preparedness Innovation (CEPI) and Gavi to support the ma...
Load More
